Favipiravir for the treatment of COVID-19 pneumonia: Can we predict the response to treatment?

Favipiravir for the treatment of COVID-19 pneumonia: Can we predict the response to treatment?

Introduction: Early experience with favipiravir in the treatment of COVID-19 is promising, but no clinical data have been published in medical journals. This study aimed to review the experience with favipiravir treatment for COVID-19 pneumonia and to examine whether there are any predictors of tre...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdullah Sayiner, Huseyin Aytac Erdem, Pervin Korkmaz Ekren, Sezai Tasbakan, Ozen K Basoglu, Meltem Isikgoz Tasbakan, Tansu Yamazhan, Deniz Gokengin, Mustafa Hikmet Ozhan
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2022-03-01
Series:Journal of Infection in Developing Countries
Subjects:
COVID-19
treatment
favipiravir
Online Access:https://jidc.org/index.php/journal/article/view/14033
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jidc.org/index.php/journal/article/view/14033

Similar Items